319 related articles for article (PubMed ID: 20300479)
1. Inflammatory mediators of hepatic steatosis.
Hijona E; Hijona L; Arenas JI; Bujanda L
Mediators Inflamm; 2010; 2010():837419. PubMed ID: 20300479
[TBL] [Abstract][Full Text] [Related]
2. Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment.
Carter-Kent C; Zein NN; Feldstein AE
Am J Gastroenterol; 2008 Apr; 103(4):1036-42. PubMed ID: 18177455
[TBL] [Abstract][Full Text] [Related]
3. Adipocytokines in nonalcoholic fatty liver disease: key players regulating steatosis, inflammation and fibrosis.
Tilg H
Curr Pharm Des; 2010 Jun; 16(17):1893-5. PubMed ID: 20370678
[TBL] [Abstract][Full Text] [Related]
4. Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants.
Mehta K; Van Thiel DH; Shah N; Mobarhan S
Nutr Rev; 2002 Sep; 60(9):289-93. PubMed ID: 12296456
[TBL] [Abstract][Full Text] [Related]
5. The role of cytokines and chemokines in the development of steatohepatitis.
Lalor PF; Faint J; Aarbodem Y; Hubscher SG; Adams DH
Semin Liver Dis; 2007 May; 27(2):173-93. PubMed ID: 17520517
[TBL] [Abstract][Full Text] [Related]
6. [Nonalcoholic fatty liver disease].
Ko JS
Korean J Gastroenterol; 2010 Jul; 56(1):6-14. PubMed ID: 20664312
[TBL] [Abstract][Full Text] [Related]
7. Role of cytokines and chemokines in non-alcoholic fatty liver disease.
Braunersreuther V; Viviani GL; Mach F; Montecucco F
World J Gastroenterol; 2012 Feb; 18(8):727-35. PubMed ID: 22371632
[TBL] [Abstract][Full Text] [Related]
8. Markers in nonalcoholic steatohepatitis.
Armutcu F; Akyol S; Ucar F; Erdogan S; Akyol O
Adv Clin Chem; 2013; 61():67-125. PubMed ID: 24015600
[TBL] [Abstract][Full Text] [Related]
9. Genetically modified mouse models for the study of nonalcoholic fatty liver disease.
Nagarajan P; Mahesh Kumar MJ; Venkatesan R; Majundar SS; Juyal RC
World J Gastroenterol; 2012 Mar; 18(11):1141-53. PubMed ID: 22468076
[TBL] [Abstract][Full Text] [Related]
10. Role of inflammation in nonalcoholic steatohepatitis.
Choi S; Diehl AM
Curr Opin Gastroenterol; 2005 Nov; 21(6):702-7. PubMed ID: 16220049
[TBL] [Abstract][Full Text] [Related]
11. Fructose as a key player in the development of fatty liver disease.
Basaranoglu M; Basaranoglu G; Sabuncu T; Sentürk H
World J Gastroenterol; 2013 Feb; 19(8):1166-72. PubMed ID: 23482247
[TBL] [Abstract][Full Text] [Related]
12. Hepatic steatosis causes induction of the chemokine RANTES in the absence of significant hepatic inflammation.
Kirovski G; Gäbele E; Dorn C; Moleda L; Niessen C; Weiss TS; Wobser H; Schacherer D; Buechler C; Wasmuth HE; Hellerbrand C
Int J Clin Exp Pathol; 2010 Aug; 3(7):675-80. PubMed ID: 20830238
[TBL] [Abstract][Full Text] [Related]
13. Insulin resistance in nonalcoholic fatty liver disease.
Bugianesi E; Moscatiello S; Ciaravella MF; Marchesini G
Curr Pharm Des; 2010 Jun; 16(17):1941-51. PubMed ID: 20370677
[TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic fatty liver disease.
Angulo P
Rev Gastroenterol Mex; 2005 Nov; 70 Suppl 3():52-6. PubMed ID: 17471859
[TBL] [Abstract][Full Text] [Related]
15. Obesity and fatty liver are 'grease' for the machinery of hepatic fibrosis.
Bosserhoff A; Hellerbrand C
Dig Dis; 2011; 29(4):377-83. PubMed ID: 21894008
[TBL] [Abstract][Full Text] [Related]
16. Nonalcoholic fatty liver disease: biochemical and therapeutic considerations.
Patrick-Melin AJ; Kalinski MI; Kelly KR; Haus JM; Solomon TP; Kirwan JP
Ukr Biokhim Zh (1999); 2009; 81(5):16-25. PubMed ID: 20387643
[TBL] [Abstract][Full Text] [Related]
17. Nonalcoholic Fatty liver disease and obesity.
Saadeh S
Nutr Clin Pract; 2007 Feb; 22(1):1-10. PubMed ID: 17242448
[TBL] [Abstract][Full Text] [Related]
18. Fatty liver: role of inflammation and fatty acid nutrition.
Byrne CD
Prostaglandins Leukot Essent Fatty Acids; 2010; 82(4-6):265-71. PubMed ID: 20189787
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and management of nonalcoholic fatty liver disease and its hemostatic/thrombotic and vascular complications.
Targher G; Byrne CD
Semin Thromb Hemost; 2013 Mar; 39(2):214-28. PubMed ID: 23397556
[TBL] [Abstract][Full Text] [Related]
20. Nonalcoholic fatty liver disease/steatohepatitis: epidemiology, pathogenesis, clinical presentation and treatment.
Milić S; Stimac D
Dig Dis; 2012; 30(2):158-62. PubMed ID: 22722431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
